🔎 Trials Near Me

Akèy › Ateroskleroz › Virginia › Arlington

Etid klinik pou Ateroskleroz nan Arlington, VA

8 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi lwen
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi lwen
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
  • Inova Cardiology - Fairfax, Fairfax · 11 mi lwen
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3
  • Nephrology Associates of Northern Virginia Inc, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Falls Church · 4 mi lwen
  • Research Site, Fairfax · 11 mi lwen
  • Research Site, Manassas · 22 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT06875973

Etid Ateroskleroz nan lòt vil

Lòt etid nan Arlington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.